1. Home
  2. SMTC vs CYTK Comparison

SMTC vs CYTK Comparison

Compare SMTC & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMTC
  • CYTK
  • Stock Information
  • Founded
  • SMTC 1960
  • CYTK 1997
  • Country
  • SMTC United States
  • CYTK United States
  • Employees
  • SMTC N/A
  • CYTK N/A
  • Industry
  • SMTC Semiconductors
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMTC Technology
  • CYTK Health Care
  • Exchange
  • SMTC Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • SMTC 4.3B
  • CYTK 4.6B
  • IPO Year
  • SMTC N/A
  • CYTK 2004
  • Fundamental
  • Price
  • SMTC $71.03
  • CYTK $59.89
  • Analyst Decision
  • SMTC Strong Buy
  • CYTK Buy
  • Analyst Count
  • SMTC 15
  • CYTK 16
  • Target Price
  • SMTC $62.87
  • CYTK $76.73
  • AVG Volume (30 Days)
  • SMTC 1.7M
  • CYTK 2.5M
  • Earning Date
  • SMTC 11-24-2025
  • CYTK 11-05-2025
  • Dividend Yield
  • SMTC N/A
  • CYTK N/A
  • EPS Growth
  • SMTC N/A
  • CYTK N/A
  • EPS
  • SMTC 0.29
  • CYTK N/A
  • Revenue
  • SMTC $996,476,000.00
  • CYTK $85,738,000.00
  • Revenue This Year
  • SMTC $15.91
  • CYTK $363.61
  • Revenue Next Year
  • SMTC $9.30
  • CYTK $64.08
  • P/E Ratio
  • SMTC $245.14
  • CYTK N/A
  • Revenue Growth
  • SMTC 22.22
  • CYTK 2635.74
  • 52 Week Low
  • SMTC $24.05
  • CYTK $29.31
  • 52 Week High
  • SMTC $79.52
  • CYTK $61.19
  • Technical
  • Relative Strength Index (RSI)
  • SMTC 67.13
  • CYTK 75.04
  • Support Level
  • SMTC $68.12
  • CYTK $47.22
  • Resistance Level
  • SMTC $74.25
  • CYTK $50.78
  • Average True Range (ATR)
  • SMTC 3.13
  • CYTK 2.30
  • MACD
  • SMTC 0.57
  • CYTK 0.66
  • Stochastic Oscillator
  • SMTC 83.24
  • CYTK 90.55

About SMTC Semtech Corporation

Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems and IoT Connected Services. The majority of the company's revenue is earned through Analog Mixed Signal and Wireless segment. Geographically majority of the company's revenue is earned from Asia Pacific region, company also operates in North America and Europe.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: